Episode
Balancing Innovation and Practicality in Immuno-Oncology Dose Selection
- Podcast
- PharmaTalkRadio
- Published
- Dec 19, 2025
- Duration seconds
- 2712
- Processing state
not_requested- Canonical source
- https://www.spreaker.com/episode/balancing-innovation-and-practicality-in-immuno-oncology-dose-selection--69135639
Actions
POST https://stenobird.com/v1/public/podcasts/pharmatalkradio-7131046/episodes/balancing-innovation-and-practicality-in-immuno-oncology-dose-selection/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/pharmatalkradio-7131046/balancing-innovation-and-practicality-in-immuno-oncology-dose-selection.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
About this podcast: Recorded at the 2025 IO360º Summit, this podcast addresses how Project Optimus is reshaping dose selection from maximum tolerated dose to a balance of efficacy and safety. More specifically, this panel addresses FDA objectives for multi-dose selection, alternative dose-selection strategies with imaging, biomarkers and tumor burden analysis, the higher costs and longer timelines, and financial impacts for early-phase oncology companies. For more information, go to IO360summit.com .